Categorical meta-analysis of Osteopontin as a clinical cancer marker

  • Authors:
    • Georg F. Weber
    • G. Scott Lett
    • Ned C. Haubein
  • View Affiliations

  • Published online on: December 13, 2010     https://doi.org/10.3892/or.2010.1106
  • Pages: 433-441
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Although extensive literature exists on cancer biomarkers few have found entry into clinical use. In particular, the cancer metastasis gene Osteopontin has been investigated extensively but it has not yet been applied to routine diagnostics. Here, we conduct a meta-analysis of data from the published literature and from RNA microarrays deposited in Oncomine. Osteopontin has been associated with 34 cancers. It is a marker for breast, cervical, colorectal, head and neck, liver, lung, ovarian and prostate cancers, as well as for sarcoma. Osteopontin is overexpressed in the metastases of colorectal cancers, lung cancers and melanomas, but not in ovarian cancer. Further, Osteopontin is indicative of the underlying mechanism of transformation only in certain virally induced tumors, where its function as a TH1 cytokine likely plays important roles. These results refine the value of Osteopontin as a cancer biomarker.

Related Articles

Journal Cover

February 2011
Volume 25 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Weber GF, Lett GS and Haubein NC: Categorical meta-analysis of Osteopontin as a clinical cancer marker. Oncol Rep 25: 433-441, 2011
APA
Weber, G.F., Lett, G.S., & Haubein, N.C. (2011). Categorical meta-analysis of Osteopontin as a clinical cancer marker. Oncology Reports, 25, 433-441. https://doi.org/10.3892/or.2010.1106
MLA
Weber, G. F., Lett, G. S., Haubein, N. C."Categorical meta-analysis of Osteopontin as a clinical cancer marker". Oncology Reports 25.2 (2011): 433-441.
Chicago
Weber, G. F., Lett, G. S., Haubein, N. C."Categorical meta-analysis of Osteopontin as a clinical cancer marker". Oncology Reports 25, no. 2 (2011): 433-441. https://doi.org/10.3892/or.2010.1106